C

Cuu Long Pharmaceutical JSC
VN:DCL

Watchlist Manager
Cuu Long Pharmaceutical JSC
VN:DCL
Watchlist
Price: 20 800 VND 3.48% Market Closed
Market Cap: 1.5T VND

Intrinsic Value

The intrinsic value of one DCL stock under the Base Case scenario is 25 829.91 VND. Compared to the current market price of 20 800 VND, Cuu Long Pharmaceutical JSC is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DCL Intrinsic Value
25 829.91 VND
Undervaluation 19%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Cuu Long Pharmaceutical JSC

DCL
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for DCL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Cuu Long Pharmaceutical JSC
VN:DCL
VN
Pharmaceuticals
Market Cap
1.5T VND
IPO
Sep 17, 2008
VN
Pharmaceuticals
Market Cap
1.5T VND
IPO
Sep 17, 2008
Price
â‚«false
EPS
â‚«false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DCL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cuu Long Pharmaceutical JSC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cuu Long Pharmaceutical JSC

Current Assets 1.5T
Cash & Short-Term Investments 221.9B
Receivables 788.6B
Other Current Assets 503.3B
Non-Current Assets 900.1B
PP&E 860.4B
Intangibles 23.2B
Other Non-Current Assets 16.5B
Efficiency

Free Cash Flow Analysis
Cuu Long Pharmaceutical JSC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cuu Long Pharmaceutical JSC

Revenue
1.2T VND
Cost of Revenue
-962.9B VND
Gross Profit
222.3B VND
Operating Expenses
-127.9B VND
Operating Income
94.3B VND
Other Expenses
-25.1B VND
Net Income
69.3B VND
Fundamental Scores

DCL Profitability Score
Profitability Due Diligence

Cuu Long Pharmaceutical JSC's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 1-Year Revenue Growth
Positive Operating Income
Positive Net Income
44/100
Profitability
Score

Cuu Long Pharmaceutical JSC's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

DCL Solvency Score
Solvency Due Diligence

Cuu Long Pharmaceutical JSC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
50/100
Solvency
Score

Cuu Long Pharmaceutical JSC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DCL Price Targets Summary
Cuu Long Pharmaceutical JSC

There are no price targets for DCL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DCL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one DCL stock?

The intrinsic value of one DCL stock under the Base Case scenario is 25 829.91 VND.

Is DCL stock undervalued or overvalued?

Compared to the current market price of 20 800 VND, Cuu Long Pharmaceutical JSC is Undervalued by 19%.

Back to Top